Trials / Completed
CompletedNCT02028377
Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma
Evaluation of the Novel Imaging Modality Simultaneous Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI) in Patients With Pancreatic Adenocarcinoma
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will use PET/MRI in patients with adenocarcinoma of the pancreas to identify hidden metastatic disease or identify patients with borderline or locally advanced disease.
Detailed description
Patients will receive a PET/MRI scan within 6 weeks of their standard of care imaging. There is no maximum number of scans for research. The number of scans depends on each patient's treatment plan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PET/MRI | PET/MRI |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2017-08-22
- Completion
- 2017-08-22
- First posted
- 2014-01-07
- Last updated
- 2018-06-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02028377. Inclusion in this directory is not an endorsement.